Prognostic Significance of Preoperative NLR, MLR, and PLR Values in Predicting the Outcome of Primary Cytoreductive Surgery in Serous Epithelial Ovarian Cancer

(1) The degree of cytoreduction achieved during primary debulking surgery (PDS) is an important prognostic factor for the survival of patients with epithelial ovarian cancer (EOC). Our aim was to investigate the prognostic value of preoperative laboratory parameters for the outcome of PDS. (2) We analyzed the preoperative laboratory parameters of 150 serous EOC patients who underwent PDS between 2006 and 2013. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal cut-off values of the variables for predicting the PDS outcome. We used binary logistic regression to examine the independent predictive value of the factors for incomplete cytoreduction. (3) Among the parameters, we established optimal cut-off values for cancer antigen (Ca)-125, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) to predict the outcome of PDS. The results of binary logistic regression showed that stage (FIGO III-IV), MLR (>0.305), and Ca-125 (>169.15 kU/L) were independent significant predictors of the degree of tumor reduction achieved during PDS. (4) In the future, MLR, especially in combination with other parameters, may be useful in determining prognosis and selecting the best treatment option (PDS or neoadjuvant chemotherapy + interval debulking surgery) for ovarian cancer patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Diagnostics (Basel, Switzerland) - 13(2023), 13 vom: 04. Juli

Sprache:

Englisch

Beteiligte Personen:

Kovács, Anna Rebeka [VerfasserIn]
Sulina, Anita [VerfasserIn]
Kovács, Kincső Sára [VerfasserIn]
Lukács, Luca [VerfasserIn]
Török, Péter [VerfasserIn]
Lampé, Rudolf [VerfasserIn]

Links:

Volltext

Themen:

Cytoreductive surgery
Epithelial ovarian cancer
Journal Article
Prognostic factors

Anmerkungen:

Date Revised 18.07.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/diagnostics13132268

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM359444067